Administrative AI can meaningfully cut providers’ price tags on prior authorization processes. Yet the technology is not doing much to reduce overall system-level costs. And it tends to increase billing intensity, inflating medical spending as it does so.
The new Class I recall, which includes more than 1.4 million devices, is related to an issue first announced back in 2024. Updating the software should address the issue going forward, though some patients may still require an early replacement.
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.
However, radiology dropped to 18th on the list of specialists when asked how they feel about their profession’s long-term future, according to new survey data from Medscape.
When Larry Ellison talks about healthcare AI, people invest. At least, that’s what happened after the Oracle chairman enthused over AI’s potential to cook up vaccines for cancer.
Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.
Tim Noel is taking the reins of the insurance giant in the aftermath of the murder of its previous CEO, Brian Thompson. Noel has been with the company since 2007.
This new information on the pathogenesis of both conditions could be useful for the development of interventions targeted at slowing cognitive decline.
Administrative AI can meaningfully cut providers’ price tags on prior authorization processes. Yet the technology is not doing much to reduce overall system-level costs. And it tends to increase billing intensity, inflating medical spending as it does so.
